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The neuropeptide oxytocin is synthesized in the brain and released from neurohypophyseal terminals
into the blood and within defined brain regions that regulate emotional, cognitive, and social behav-
iors. A recent study of CD38/ mice (Jin et al., 2007) has demonstrated an essential role for the
transmembrane receptor CD38 in secretion of oxytocin into the blood.The neuropeptide oxytocin has at-
tracted intense attention due to the
discovery of its amazing variety of
behavioral functions. Oxytocin and
the related nonapeptide vasopressin
are essential parts of the hypotha-
lamo-neurohypophyseal system. First
described in 1928 by the German biol-
ogist Ernst Scharrer in fish, this clearly
delineated, compact arrangement of
relatively large neurons at the base of
the brain with long axonal projections
to the neurohypophysis and contacts
with blood capillaries has served as
a valuable model system in neuroen-
docrinology and neuroscience. Oxyto-
cin was the first neuropeptide to be
characterized (by Du Vigneaud and, in-
dependently, by Acher in the 1950s).
Studies of oxytocin have provided key
insights into the bursting pacemaker
activity of neurosecretory neurons,
neuropeptidergic pathways and re-
lease patterns within the brain, neuro-
nal-glial interactive plasticity, neuro-
peptide receptor antagonists, and,
importantly, behavior (reviewed in
Poulain et al., 2002). Work over the
past two decades has illuminated themolecular and cellular mechanisms of
neuronal oxytocin synthesis, trans-
port, processing, and release, both
into the blood and within the brain
(Landgraf and Neumann, 2004). These
findings have been causally linked to
behavioral and other phenomena in
both animal and human studies (Fig-
ure 1). Brain oxytocin modulates social
behaviors, includingmaternal care and
aggression, pair bonding, sexual be-
havior, social memory and support,
and human trust, and downregulates
stress responses, including anxiety.
Thus, while neuropeptides such as va-
sopressin and CRH might represent
the Homerian sea monsters Scylla
and Charybdis in behavioral regula-
tion, oxytocin, like Circe and Thetis
(who guided Odysseus to avoid both
dangers) would mediate anxiolytic
and prosocial influences, beneficial to
relief, reproduction, and love (Landgraf
et al., 2007). This system is therefore
one of the most promising neuromo-
dulator/neurotransmitter systems of
the brain for psychotherapeutic inter-
vention and treatment of numerous
psychiatric illnesses, for example so-Cell Metabolcial phobia, autism, and postpartum
depression.
A recent article in Nature by Higa-
shida and colleagues (Jin et al., 2007)
sheds a bright light on the molecular
and cellular mechanisms of neuronal
oxytocin release. The authors apply an
impressive variety of molecular, cellu-
lar, neuroendocrine, and behavioral
techniques to convincingly character-
ize the transmembrane receptor CD38
as an essential component in the se-
cretory machinery of oxytocin neu-
rons. CD38 can catalyze the formation
of the secondmessengers cyclic ADP-
ribose (cADPR) and nicotinic acid ade-
nine dinucleotide phosphate (NAADP),
which are essential for the activation of
intracellular Ca2+ stores (Empson and
Galione, 1997). In the presence of
calmodulin, increasing the concentra-
tion of cADPR increases the sensitivity
of Ca2+-induced Ca2+ release (Lee,
2005). Thus, application of cADPR
through a patch-clamp pipette aug-
ments the action-potential-induced,
and ryanodine-sensitive, rise in intra-
cellular Ca2+. These CD38-dependent
cADPR and NAADP signalingism 5, April 2007 ª2007 Elsevier Inc. 231
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PreviewsFigure 1. Multiple Actions of Brain Oxytocin
Oxytocin is released within defined brain regions upon appropriate stimulation, where it regulates
not only neuroendocrine and autonomic functions related to reproduction but also prosocial be-
haviors (supported by its cognitive effects) and emotional responses contributing to the general
phenomena of relaxation, trust, and psychological stability.pathways play an essential role in exo-
cytosis of neurotransmitters in both in-
vertebrates and vertebrates (Lee,
2005).
Jin et al. (2007) use mice lacking the
CD38 gene (CD38/) to demonstrate
that this transmembrane protein is es-
sential for adequate oxytocin release
from hypothalamic neurons. CD38/
mice have reduced plasma oxytocin
concentrations, and their hypophyseal
terminals contain more oxytocin as
well as dense core vesicles, indicating
excessive peptide storage and im-
paired peptide release. Moreover, the
authors’ findings strongly suggest
the critical involvement of cADPR-
mediated and NAADP-sensitive Ca2+
mobilization from intracellular stores in
oxytocin release from neurohypophy-
seal terminals, as oxytocin secretion
can be evoked by 100 nM NAADP in
CD38/ mice. Interestingly, release of
vasopressin was apparently normal in
CD38/ mice. This is evidence for a
highly neuropeptide-selective neurose-
cretory mechanism and might explain
stimulus-dependent activation of either
oxytocin or vasopressin secretion.
The impairment of neuronal oxytocin
release in CD38/ mice is accompa-
nied by significant behavioral abnor-
malities. For example, the latency to
retrieve pups in the home cage is
prolonged, indicating impaired mater-
nal care under stressful conditions,
which is likely related to a deficit in in-232 Cell Metabolism 5, April 2007 ª2007tracerebral oxytocin release. However,
growth and development of pups in
offspring of CD38/ dams was not
altered, indicating normal maternal be-
havior under unstressed conditions in
the home cage. Taking into account
that oxytocin is the only factor that trig-
gers milk ejection in response to the
suckling stimulus (Nishimori et al.,
1996), it seems that CD38 is only a co-
factor for suckling-induced oxytocin
secretion. It would be interesting to
see whether lack of CD38 has conse-
quences not only on basal but also
on stimulated oxytocin secretion into
blood, for example in response tosuck-
ling or during exposure to stressors.
Importantly, CD38/ mice show
substantial impairment of social mem-
ory and in the recognition of a conspe-
cific female. This is in agreement with
the demonstration that intracerebral
oxytocin is important for social mem-
ory (Dluzen et al., 2000; Ferguson et al.,
2000). Jin et al. (2007) go on to rescue
deficits in oxytocin release and related
behaviors by infusion of a lentiviral
vector carrying the human CD38 gene
into the ventricular system of the brain,
with consequent increases in CD38
protein expression in the hypothalamus
and neurohypophysis. These data
show that the rise in intracellular Ca2+
and subsequent oxytocin release
require this transmembrane protein.
Jin et al. (2007) also demonstrate
rescue of the behavioral abnormalitiesElsevier Inc.of CD38/ mice by peripheral oxyto-
cin injection. One interpretation of the
data is that the cognitive deficits seen
in the knockouts stem from impaired
oxytocin release. However, taking
into account the relatively high plasma
and CSF oxytocin concentrations in
mice of about 200 ng/ml in CD38/
and 400 ng/ml in CD38+/+ (roughly
10,000-fold higher than in rats or
humans), it is puzzling how subcutane-
ous injection of a total of 1–10 ng/kg
(i.e., of about 30 to 300 pg per adult
mouse; see Supplementary Figure S7
in Jin et al., 2007) could substantially
increase CSF oxytocin concentrations
in CD38/ mice (from 200 to 350
ng/ml). This would imply a selective
neuropeptide uptake into the brain,
complicated or limited by the pres-
ence of the blood-brain barrier. More-
over, the general well-being of the
CD38/ mice (as measured by
behavioral indicators including loco-
motion and anxiety) would seem to
rule out a pathologically increased
permeability of the blood-brain barrier
in these animals. Another possibility,
which warrants further study, is that
small additional quantities of oxytocin
might trigger substantial oxytocin
release from the described overfull
neuronal stores via autoexcitatory
mechanisms.
Whatever the underlying mecha-
nisms, the rescue of social memory
by oxytocin in CD38/ mice implies
that lack of CD38 also affects intrace-
rebral oxytocin release. Clearly, oxyto-
cin release within distinct brain regions
(which can be monitored in conscious
mice by intracerebral microdialysis
[Theodosis et al., 2004]) and into the
blood may occur independently (Neu-
mann et al., 1993). In particular, den-
dritic release follows different neuronal
mechanisms (Ludwig et al., 2004).
Thus, a distinction between neuro-
hypophyseal oxytocin secretion and
release within defined brain regions
would help to interpret the behavioral
alterations in CD38/mice.
Taken together, the comprehensive
data of Higashida and coworkers (Jin
et al., 2007) provide important insights
into the complex mechanisms of oxy-
tocin secretion, with CD38 being an
essential part for appropriate neuro-
peptide responses and actions. Given
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Previewsthe behavioral consequences of lack
of CD38, it seems likely that CD38-
mediated mechanisms are also in-
volved in the release of oxytocin (and
possibly other neuropeptides) within
the brain. The results make a search
for human CD38 mutations tempting,
for example in patients with severe
disturbances in social behaviors, in-
cluding social phobia and autism.
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The Pearl-Harman notion was that
faster metabolism (increased oxygen
consumption) leads to increased reac-
tive oxygen species (ROS) formation
and hence shorter life span. Surpris-
ingly, three-quarters of a century after
Pearl’s initial treatise, the molecular
basis for differences in metabolic rate
within and between organisms, as
well as the relationship between oxy-
gen consumption and ROS formation,
remains largely unknown. Now, a pa-
per in this month’s issue ofCell Metab-
olism begins to peel away the mystery
surrounding some of these decades-
old questions (Bonawitz et al., 2007).
The current work centers on the
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eterminants of life span. A new
s that the TOR pathway controls
work, the longer yeast live.
logical life span is the length of time
that a nondividing yeast cell can re-
main viable in culture. In mammals,
this distinction may be analogous to
assessing aging in dividing versus
postmitotic cells. S. cerevisiae has
two TOR genes that are partially but
not completely redundant. Yeast de-
leted in the TOR2 gene are not viable,
while deletion of TOR1 increases
replicative life span (Kaeberlein et al.,
2005). In general, TOR represents
a central signaling node that coordi-
nates cell growth with the underlying
cellular energy state. In the presence
of nutrients, when the energy stores
of a yeast cell are high, TOR coordi-
nates increases in translation, tran-
scription, and ribosomal biogenesis
while inhibiting the self-consuming
process of autophagy. Interestingly,
diminished TOR signaling can also ex-
tend the life span of other organisms
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